{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:16:49Z","timestamp":1790612209134,"version":"4.1.0"},"reference-count":21,"publisher":"Oxford University Press (OUP)","issue":"Supplement_4","license":[{"start":{"date-parts":[[2022,7,26]],"date-time":"2022-07-26T00:00:00Z","timestamp":1658793600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,11,22]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Patients on hemodialysis have a high risk of medication-related problems. Studies using deprescribing algorithms to reduce the number of inappropriate medications in this population have been published, but none have used a patient-partnership approach. Our study evaluated the impact of a similar intervention with a patient-partnership approach.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The objective was to describe the implementation of a pharmacist-led intervention with a patient-partnership approach using deprescribing algorithms and its impact on the reduction of inappropriate medications in patients on hemodialysis. Eight algorithms were developed by pharmacists and nephrologists to assess the appropriateness of medications. Pharmacists identified patients taking targeted medications. Following patient enrollment, pharmacists assessed medications with patients and applied the algorithms. With patient consent, deprescription was suggested to nephrologists if applicable. Specific data on each targeted medication were collected at 4 and 16 weeks. Descriptive statistics were used to examine the effects of the deprescribing intervention.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 270 patients, 256 were taking at least one targeted medication. Of the 122 patients taking at least one targeted medication who were approached to participate, 66 were included in the study. At enrollment, these patients were taking 252 targeted medications, of which 59 (23.4%) were determined to be inappropriate. Deprescription was initiated for 35 of these 59 medications (59.3%). At 4 weeks, 33 of the 59 medications (55.9%) were still deprescribed, while, at 16 weeks, 27 of the 59 medications (45.8%) were still deprescribed. Proton pump inhibitors and benzodiazepines or Z-drugs were the most common inappropriate medications, and allopurinol was the most deprescribed medication.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>A pharmacist-led intervention with a patient-partnership approach and using deprescribing algorithms reduced the number of inappropriate medications in patients on hemodialysis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ajhp\/zxac190","type":"journal-article","created":{"date-parts":[[2022,7,26]],"date-time":"2022-07-26T16:29:01Z","timestamp":1658852941000},"page":"S128-S135","source":"Crossref","is-referenced-by-count":18,"title":["Implementation of targeted deprescribing of potentially inappropriate medications in patients on hemodialysis"],"prefix":"10.1093","volume":"79","author":[{"given":"Savannah","family":"Gerardi","sequence":"first","affiliation":[{"name":"D\u00e9partement de Pharmacie, CISSS de Laval , Laval, QC , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Sperlea","sequence":"additional","affiliation":[{"name":"D\u00e9partement de Pharmacie, CIUSSS du Centre-Ouest-de-l\u2019\u00cele-de-Montr\u00e9al , Montr\u00e9al, QC , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirel Ora-Lee","family":"Levy","sequence":"additional","affiliation":[{"name":"D\u00e9partement de Pharmacie, CIUSSS du Nord-de-l\u2019\u00cele-de-Montr\u00e9al , Montr\u00e9al, QC , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaitlin","family":"Bondurant-David","sequence":"additional","affiliation":[{"name":"D\u00e9partement de Pharmacie, CIUSSS du Centre-Sud-de-l\u2019\u00cele-de-Montr\u00e9al , Montr\u00e9al, QC , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Dang","sequence":"additional","affiliation":[{"name":"D\u00e9partement de Pharmacie, CIUSSS de la Mauricie-et-du-Centre-du-Qu\u00e9bec , Trois-Rivi\u00e8res, QC , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Marie","family":"David","sequence":"additional","affiliation":[{"name":"Facult\u00e9 de Pharmacie, Universit\u00e9 de Montr\u00e9al , Montr\u00e9al, QC , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie","family":"Lizotte","sequence":"additional","affiliation":[{"name":"D\u00e9partement de Pharmacie, CISSS de Laval , Laval, QC , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lysane","family":"Sen\u00e9cal","sequence":"additional","affiliation":[{"name":"D\u00e9partement de Pharmacie, CISSS de Laval , Laval, QC , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Paquette","sequence":"additional","affiliation":[{"name":"D\u00e9partement de N\u00e9phrologie, CISSS de Laval , Laval, QC , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Claude","family":"Vanier","sequence":"additional","affiliation":[{"name":"Facult\u00e9 de Pharmacie, Universit\u00e9 de Montr\u00e9al , Montr\u00e9al, QC"},{"name":"D\u00e9partement de Pharmacie, CISSS de Laval , Laval, QC , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,7,26]]},"reference":[{"issue":"6","key":"2022112209342800700_CIT0001","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.2215\/CJN.00290109","article-title":"Pill burden, adherence, hyperphosphatemia, and quality of life in maintenance dialysis patients","volume":"4","author":"Chiu","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"2022112209342800700_CIT0002","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1053\/j.ajkd.2017.02.374","article-title":"Targeted deprescribing in an outpatient hemodialysis unit: a quality improvement study to decrease polypharmacy","volume":"70","author":"McIntyre","year":"2017","journal-title":"Am J Kidney Dis."},{"issue":"7","key":"2022112209342800700_CIT0003","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1093\/ndt\/gfh280","article-title":"Medication prescribing patterns in ambulatory haemodialysis patients: comparisons of USRDS to a large not-for-profit dialysis provider","volume":"19","author":"Manley","year":"2004","journal-title":"Nephrol Dial Transplant"},{"issue":"12","key":"2022112209342800700_CIT0004","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1592\/phco.29.12.1433","article-title":"Reduced drug use and hospitalization rates in patients undergoing hemodialysis who received pharmaceutical care: a 2-year, randomized, controlled study","volume":"29","author":"Pai","year":"2009","journal-title":"Pharmacotherapy"},{"key":"2022112209342800700_CIT0005","first-page":"76","article-title":"Polypharmacy and medication-related problems in hemodialysis patients: a call for deprescribing. Pharmacy","author":"Alshamrani","year":"2018"},{"key":"2022112209342800700_CIT0006","doi-asserted-by":"crossref","first-page":"2054358118760832","DOI":"10.1177\/2054358118760832","article-title":"A province-wide, cross-sectional study of demographics and medication use of patients in hemodialysis units across Ontario","volume":"5","author":"Battistella","year":"2018","journal-title":"Can J Kidney Health Dis"},{"issue":"12","key":"2022112209342800700_CIT0007","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1111\/jgs.13153","article-title":"Health outcomes associated with polypharmacy in community-dwelling older adults: a systematic review","volume":"62","author":"Fried","year":"2014","journal-title":"J Am Geriatr Soc"},{"issue":"4","key":"2022112209342800700_CIT0008","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.nephro.2005.08.002","article-title":"Analyse critique des prescriptions m\u00e9dicamenteuses en h\u00e9modialyse [Medical prescriptions in haemodialysis patients: critical analysis]","volume":"1","author":"Riemer","year":"2005","journal-title":"Nephrol Ther"},{"issue":"12","key":"2022112209342800700_CIT0009","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1111\/bcp.13738","article-title":"Evaluation of the adequacy of drug prescriptions in patients with chronic kidney disease: results from the CKD-REIN cohort","volume":"84","author":"Laville","year":"2018","journal-title":"Br J Clin Pharmacol"},{"key":"2022112209342800700_CIT0010","first-page":"890","article-title":"Active deprescribing program in chronic kidney disease patients undergoing haemodialysis. Nephrology","author":"George","year":"2021"},{"issue":"18","key":"2022112209342800700_CIT0011","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1001\/jama.2018.16131","article-title":"Effect of a pharmacist-led educational intervention on inappropriate medication prescriptions in older adults: the D-PRESCRIBE randomized clinical trial","volume":"320","author":"Martin","year":"2018","journal-title":"JAMA"},{"issue":"4","key":"2022112209342800700_CIT0012","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1136\/eb-2012-100930","article-title":"Deciding when to stop: towards evidence-based deprescribing of drugs in older populations","volume":"18","author":"Scott","year":"2013","journal-title":"Evid Based Med"},{"issue":"1","key":"2022112209342800700_CIT0013","doi-asserted-by":"crossref","first-page":"144","DOI":"10.2215\/CJN.05270420","article-title":"Addressing polypharmacy in outpatient dialysis units","volume":"16","author":"Battistella","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"2022112209342800700_CIT0014","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/ijpp.12674","article-title":"Issues with deprescribing in haemodialysis: a qualitative study of patient and provider experiences","volume":"28","author":"Bondurant-David","year":"2020","journal-title":"Int J Pharm Pract"},{"key":"2022112209342800700_CIT0015","author":"Bruy\u00e8re Research Institute"},{"issue":"9","key":"2022112209342800700_CIT0016","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1111\/jgs.12418","article-title":"People\u2019s attitudes, beliefs, and experiences regarding polypharmacy and willingness to deprescribe","volume":"61","author":"Reeve","year":"2013","journal-title":"J Am Geriatr Soc"},{"issue":"6","key":"2022112209342800700_CIT0017","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/fampra\/cmu050","article-title":"Strategies for discontinuation of proton pump inhibitors: a systematic review","volume":"31","author":"Haastrup","year":"2014","journal-title":"Fam Pract"},{"issue":"7","key":"2022112209342800700_CIT0018","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1517\/14740338.2014.925444","article-title":"Risk versus risk: a review of benzodiazepine reduction in older adults","volume":"13","author":"Paquin","year":"2014","journal-title":"Expert Opin Drug Saf"},{"issue":"11","key":"2022112209342800700_CIT0019","first-page":"832","article-title":"Deprescribing antihyperglycemic agents in older persons: evidence-based clinical practice guideline","volume":"63","author":"Farrell","year":"2017","journal-title":"Can Fam Physician"},{"issue":"4","key":"2022112209342800700_CIT0020","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.sapharm.2016.08.006","article-title":"Community-dwelling older people\u2019s attitudes towards deprescribing in Canada","volume":"13","author":"Sirois","year":"2017","journal-title":"Res Social Adm Pharm"},{"key":"2022112209342800700_CIT0021","doi-asserted-by":"crossref","first-page":"2054358120968674","DOI":"10.1177\/2054358120968674","article-title":"Development and validation of nine deprescribing algorithms for patients on hemodialysis to decrease polypharmacy","volume":"7","author":"Lefebvre","year":"2020","journal-title":"Can J Kidney Health Dis"}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajhp\/advance-article-pdf\/doi\/10.1093\/ajhp\/zxac190\/45186752\/zxac190.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajhp\/article-pdf\/79\/Supplement_4\/S128\/47115584\/zxac190.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajhp\/article-pdf\/79\/Supplement_4\/S128\/47115584\/zxac190.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T04:35:54Z","timestamp":1669091754000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/79\/Supplement_4\/S128\/6650307"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,26]]},"references-count":21,"journal-issue":{"issue":"Supplement_4","published-online":{"date-parts":[[2022,7,26]]},"published-print":{"date-parts":[[2022,11,22]]}},"URL":"https:\/\/doi.org\/10.1093\/ajhp\/zxac190","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,12,1]]},"published":{"date-parts":[[2022,7,26]]}}}